Ligand Pharmaceuticals Incorporated (LGND)

NASDAQ: LGND · Real-Time Price · USD

232.32

-9.47 (-3.92%)

At close: Apr 28, 2026, 4:00 PM EDT

232.33

+0.01 (0.00%)

After-hours: Apr 28, 2026, 5:27 PM EDT

Ligand Pharmaceuticals Market Cap

Ligand Pharmaceuticals has a market cap or net worth of $4.66 billion as of April 28, 2026. Its market cap has increased by 138.68% in one year.

Market Cap

4.66B

Enterprise Value

4.37B

1-Year Change

138.68%

Ranking

#1418

Market Cap Chart

Since December 1, 1998, Ligand Pharmaceuticals's market cap has increased from $430.80M to $4.66B, an increase of 980.62%. That is a compound annual growth rate of 9.07%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	4.82B	29.57%
Dec 31, 2025	3.72B	83.80%
Dec 31, 2024	2.02B	62.58%
Dec 29, 2023	1.25B	10.35%
Dec 30, 2022	1.13B	-56.28%
Dec 31, 2021	2.58B	61.30%
Dec 31, 2020	1.60B	-12.63%
Dec 31, 2019	1.83B	-36.49%
Dec 31, 2018	2.88B	-0.20%
Dec 29, 2017	2.89B	36.08%
Dec 30, 2016	2.12B	-1.70%
Dec 31, 2015	2.16B	102.78%
Dec 31, 2014	1.07B	-0.76%
Dec 31, 2013	1.07B	159.26%
Dec 31, 2012	414.10M	77.34%
Dec 30, 2011	233.50M	33.50%
Dec 31, 2010	174.90M	-28.67%
Dec 31, 2009	245.20M	-5.73%
Dec 31, 2008	260.10M	-43.57%
Dec 31, 2007	460.90M	-46.88%
Dec 29, 2006	867.60M	4.96%
Dec 30, 2005	826.60M	-3.95%
Dec 31, 2004	860.60M	-19.85%
Dec 31, 2003	1.07B	179.68%
Dec 31, 2002	383.90M	-64.11%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
CG Oncology	5.61B
Scholar Rock Holding	5.44B
Caris Life Sciences	5.35B
Apellis Pharmaceuticals	5.24B
Xenon Pharmaceuticals	5.19B
TG Therapeutics	5.18B
Corcept Therapeutics	5.05B
CRISPR Therapeutics AG	4.93B

Market Cap Rankings